Boundless Bio, Inc.
company in San Diego, United States
BOLD Nasdaq
SEC CIK 1782303
Follow Boundless Bio
Weekly email: filings, results, news
Net income
−$23.7M
−51.2% vs same quarter last year
EPS, diluted
−$1.06
−51.4% vs same quarter last year
Operating cash flow
−$21M
−77.3% vs same quarter last year
Operating income
−$24.4M
−42.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$58.2M |
| FY24 | −$65.4M |
| FY23 | −$49.4M |
| FY22 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$47.2M |
| FY24 | −$63.4M |
| FY23 | −$47.5M |
| FY22 | - |
News
No stories filed under Boundless Bio yet - coverage appears here as the news feed clusters it.